A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Conditions

Diseases of the Lung | Diseases of the Respiratory Systems

Phase IIB

Volunteers
Health Professionals

What is the purpose of this trial?

Brief Summary:

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.

Ages
40 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Galecto Biotech AB
Start Date
11/17/2019
End Date
03/30/2021

For more information about this study, contact:

Donna Carrano

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Danielle Antin-Ozerkis, MD
Associate Professor of Medicine (Pulmonary)

Sub-Investigators

Last Updated
12/09/2019
Study HIC
#2000025337

A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information